Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Vermylen

Showing results (21-30 of 373) with videos related to

Pageof 38
Sort By:
Oral Surgery, Oral Medicine, and Oral Pathology|January 1, 1985
Dental extractions in hemophilia: reflections on 10 years' experienceF Vinckier, J Vermylen
Lancet (London, England)|August 12, 1995
Fatal complication of desmopressinJ Vermylen, K Peerlinck
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|January 1, 1982
[Prostaglandins, thrombosis and hemorrhage]M Verstraete, J Vermylen
Cardiovascular Drugs and Therapy|February 1, 1992
Thromboxane synthase inhibitors and receptor antagonistsJ Vermylen, H Deckmyn
Acta Clinica Belgica|January 1, 1977
[Current advances in the diagnosis, prevention and treatment of thrombosis]R Masure, J Vermylen
The Journal of Laboratory and Clinical Medicine|July 1, 1992
Is the antiphospholipid syndrome caused by antibodies directed against physiologically relevant phospholipid-protein complexes?J Vermylen, J Arnout
Lupus|November 14, 1998
Mechanism of action of beta2-glycoprotein I-dependent lupus anticoagulantsJ Arnout, J Vermylen
British Journal of Haematology|October 1, 1976
Factor VIII and human platelet aggregation. I. Evience that the platelet aggregating activity of bovine factor VIII is a property of its 'carrier protein' subunitD Bottecchia, J Vermylen
British Journal of Haematology|October 1, 1976
Factor VIII and human platelet aggregation. II. Characteristics of aggregation of human platelets by bovine factor VIIID Bottecchia, J Vermylen
Lancet (London, England)|September 18, 1993
Factor VIII preparations: need for prospective pharmacovigilanceJ Vermylen, E Briët
Pageof 38

Showing results (21-30 of 373) with videos related to

Sort By:
Pageof 38
Oral Surgery, Oral Medicine, and Oral Pathology|January 1, 1985
Dental extractions in hemophilia: reflections on 10 years' experienceF Vinckier, J Vermylen
Lancet (London, England)|August 12, 1995
Fatal complication of desmopressinJ Vermylen, K Peerlinck
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|January 1, 1982
[Prostaglandins, thrombosis and hemorrhage]M Verstraete, J Vermylen
Cardiovascular Drugs and Therapy|February 1, 1992
Thromboxane synthase inhibitors and receptor antagonistsJ Vermylen, H Deckmyn
Acta Clinica Belgica|January 1, 1977
[Current advances in the diagnosis, prevention and treatment of thrombosis]R Masure, J Vermylen
The Journal of Laboratory and Clinical Medicine|July 1, 1992
Is the antiphospholipid syndrome caused by antibodies directed against physiologically relevant phospholipid-protein complexes?J Vermylen, J Arnout
Lupus|November 14, 1998
Mechanism of action of beta2-glycoprotein I-dependent lupus anticoagulantsJ Arnout, J Vermylen
British Journal of Haematology|October 1, 1976
Factor VIII and human platelet aggregation. I. Evience that the platelet aggregating activity of bovine factor VIII is a property of its 'carrier protein' subunitD Bottecchia, J Vermylen
British Journal of Haematology|October 1, 1976
Factor VIII and human platelet aggregation. II. Characteristics of aggregation of human platelets by bovine factor VIIID Bottecchia, J Vermylen
Lancet (London, England)|September 18, 1993
Factor VIII preparations: need for prospective pharmacovigilanceJ Vermylen, E Briët
Pageof 38